21253 ⎘
Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations; Neutron capture therapy, e.g. using uranium or non-boron material Boron neutron capture therapy, i.e. BNCT, e.g. using boronated porphyrins
Methods of Performing Boron Neutron Capture Therapy (BNCT) in Combination with Immune Checkpoint Inhibitors to Enhance BNCT and the Anti-tumor effects of Immune Check Point Inhibitors as well as the Abscopal Effect Induced by Radiation Therapy and Methods Thereof
#2STARCH-BASED HYDROGEL FOR ADMINISTRATION OF THERAPEUTIC ANTICANCER AGENTS
#3BORONATED HYDROGELS AND METHODS OF MAKING AND USING THE SAME
#4Payload-Polymer-Protein Conjugates
#5NOVEL BORON AGENT
#6METAL BORIDE NANOPARTICLE FOR CANCER DIAGNOSIS AND THERAPEUTIC TREATMENT
#7SYSTEMS AND METHODS UTILIZING THERANOSTIC AGENTS FOR BPCT AND BNCT FOR TARGETED CANCER TREATMENT
#8BORONIC ACID-CONTAINING MODIFIED POLYROTAXANE
#9Synthesis for Borylated Amino Acid Compositions Comprising TC220 and TC221 For Use in Boron Neutron Capture Therapy and Methods Thereof
#10Trifluoroborate (BF3) Compositions For Use In Boron Neutron Capture Therapy and Methods Thereof
#11PHARMACEUTICAL COMPOSITION COMPRISING P-BORONOPHENYLALANINE
#12Borylated Amino Acid Compositions For Use In Boron Neutron Capture Therapy and Methods Thereof
#13FAP-TARGETED NEUTRON CAPTURE AGENTS, AND USES AND FORMULATIONS RELATED THERETO
#14SURFACE-MODIFIED NANOPARTICLE
#15BORONO-PHENYLALANINE DERIVATIVE
#16SMALL MOLECULES FOR BORON NEUTRON CAPTURE THERAPY
#17INTEGRATED LITHIUM TARGET
#18SMALL MOLECULES FOR BORON NEUTRON CAPTURE THERAPY
#19Carborane hydroxamic acid matrix metalloproteinase inhibitors and agents for boron neutron capture therapy
#20BORON CARRYING AGENT FOR INTEGRATED TUMOR DIAGNOSIS AND TREATMENT, AND PREPARATION METHOD THEREFOR AND USE THEREOF
#21Borylated amino acid compositions for use in boron neutron capture therapy and methods thereof
#22Systems, Devices, and Methods for Converting a Neutron Beam
#23METHOD FOR PREVENTING PRECIPITATION OF INJECTABLE SOLUTION CONTAINING p-BORONOPHENYLALANINE
#24INJECTION CONTAINING p-BORONOPHENYLALANINE
#25POLYMER DRUG
#26Neutron capture therapy system and target for particle beam generating device
#27Methods of Performing Neutron Capture Therapy
#28METHOD OF PRODUCING A COMPOSITION FOR BORON NEUTRON CAPTURE THERAPY OF MALIGNANT TUMORS (EMBODIMENTS)
#29Carborane hydroxamic acid matrix metalloproteinase inhibitors and agents for boron neutron capture therapy
#30NANOPARTICLES FOR BORON NEUTRON CAPTURE THERAPY AND FOR DIAGNOSING, DETECTING, AND TREATING CANCER
#31NEUTRON BEAM DYNAMIC THERAPY
#32Payload-Polymer-Protein Conjugates
#33NANO-SILICA PARTICLES CONTAINING BORON ISOTOPE AND SERVING AS BORON NEUTRON CAPTURE AGENT
#34BORIC ACID-CONTAINING POLYVINYL ALCOHOL NANOPARTICLE AND PREPARATION METHOD THEREOF
#35Borylated amino acid compositions for use in boron neutron capture therapy and methods thereof
#36Boron-10 containing biocompatible nanostructures
#37Measurement device and measurement probe
#38NEUTRON CAPTURE THERAPY SYSTEM AND CONTROL DEVICE
#39Biodegradable nanocarrier(s) (BPMOs) for neutron capture therapy and methods thereof
#40Neutron capture therapy system and target for particle beam generating device
#41Neutron capture therapy system
#42NEUTRON CAPTURE THERAPY FOR INFECTION CONTROL OF SURGICAL IMPLANTS
#43NEUTRON CAPTURE THERAPY SYSTEM AND TARGET FOR PARTICLE BEAM GENERATING DEVICE
#44System for the direct production of therapeutic yttrium-90 for cancer treatment
#45Conjugates comprising an anti-EGFR1 antibody
#46Neutron capture therapy system and therapy planning system for neutron capture therapy
#47Boron-containing compound
#48Compound for specifically binding to amyloid β-protein
#49NEUTRON CAPTURE THERAPY SYSTEM FOR ELIMINATING AMYLOID Beta-PROTEIN DEPOSITION PLAQUE
#50Neutron capture therapy system for eliminating amyloid β-protein
#51Boron neutron capture therapy system
#52Compound for specifically binding to amyloid β-protein
#53Environmentally sensitive compositions comprising a pH-triggered membrane protein and methods of use thereof in the treatment and diagnosis of tumors
#54Proton induced boron capture therapy
#55Ion implantation of neutron capture elements into nanodiamond particles to form composition for neutron capture therapy usage
#56Payload-Polymer-Protein Conjugates
#57NANOPARTICLE-MEDIATED ABLATION OF GLIOBLASTOMA AND OF OTHER MALIGNANCIES
#58Conjugates comprising an anti-EGFR1 antibody
#59Peptides whose uptake by cells is controllable
#60COMPOSITIONS AND METHODS FOR BORON NEUTRON CAPTURE THERAPY
#61Environmentally sensitive compositions and methods of use thereof
#62Image guided boronated glucose neutron capture therapy
#63Proton induced boron capture therapy
#64Pharmaceutical formulations
#65Boron cluster-modified PEG lipid derivative, and molecular assembly using same
#66Cancer treatment
#67LM-antibodies, functional fragments, LM-1 target antigen, and methods for making and using same
#68Environmentally sensitive compositions and methods of use in the treatment and diagnosis of tumors
#69Enriched 10-boron composition for cancer therapy and a method of synthesizing the same
#70Use of boric acid in boron neutron capture therapy for liver cancer
#71Activatable cell penetrating peptides with quenched fluorophores
#72Carbonylporphyrins and uses thereof
#73Methods and compositions for targeted drug delivery
#74Alpha-fetoprotein Immu31 antibodies and fusion proteins and methods of use thereof
#75Peptides whose uptake by cells is controllable
#76Alpha-fetoprotein Immu31 antibodies and fusion proteins and methods of use thereof
#77METHOD FOR PRODUCING BSH DERIVATIVE AND BSH DERIVATIVE
#78Methods for radiolabeling synthetic polymers
#79Methods for radiolabeling macromolecules
#80Hypoxia-selective, weakly basic 2-nitroimidazole delivery agents and methods of use thereof
#81NANOTUBES FOR CANCER THERAPY AND DIAGNOSTICS
#82NANOTUBES FOR CANCER THERAPY AND DIAGNOSTICS
#83NANOTUBES FOR CANCER THERAPY AND DIAGNOSTICS
#84COMPOUNDS AND METHODS FOR THE DETECTION OF TRPV-6 CANCERS AND DRUG DELIVERY
#85LM-1 ANTIBODIES, FUNCTIONAL FRAGMENTS, LM-1 TARGET ANTIGEN, AND METHODS FOR MAKING AND USING SAME
#86Agents for magnetic imaging method
#87Alpha-fetoprotein Immu31 antibodies and fusion proteins and methods of use thereof
#88CARBORANE-PHOSPHONIUM COMPOUNDS AND THEIR USE IN BORON NEUTRON CAPTURE THERAPY AND IMAGING
#89Process for the preparation of a boron-substituted porphyrin
#90Radionuclide labeling of Vitamin B12 and Co-enzymes thereof
#91LIPOSOME FORMULATIONS OF BORONIC ACID COMPOUNDS
#92LIPOSOME COMPOSITIONS FOR IN VIVO ADMINISTRATION OF BORONIC ACID COMPOUNDS
#93COBALAMIN CONJUGATES USEFUL AS ANTITUMOR AGENTS
#94Nanotubes for cancer therapy and diagnostics
#95Boron compound-layered double hydroxide nanohybrid, method of preparing the boron compound-LDH nanohybrid, and pharmaceutical composition comprising the boron compound-LDH nanohybrid
#96Glycosylated Carboranylporphyrins and Uses Thereof
#97Symmetric and asymmetric halogen-containing metallocarboranylporphyrins and uses thereof
#98Neutron Capture Therapy
#99Alpha-fetoprotein Immu31 antibodies and fusion proteins
#100Carboranylporphyrins and uses thereof
#101Hypoxia-selective, weakly basic 2-nitroimidazole delivery agents and methods of use thereof
#102Compositions of pharmaceuticals for use in low energy neutron therapy
#103Boronated metal-phthalocyanines, process for their preparation, pharmaceutical compositions comprising them and use thereof
#104Conjugates of N-hydroxypropymethacrylamide-methacrylate copolymer with nuclide activation agent and/or anti-cancer compounds
#105Methods and compositions for targeted drug delivery
#106Radionuclide labeling of vitamin Band coenzymes thereof
#107Peptides whose uptake by cells is controllable
#108Human kininogen D3 domain polypeptide as an anti-angiogenic and anti-tumor agent
#109Boronated metal-phthalocyanines, process for their preparation, pharmaceutical compositions comprising them and use thereof
#110Devices and compositions containing boron and silicon for use in neutron capture therapy
#111Nanotubes for cancer therapy and diagnostics
#112Peptides whose uptake by cells is controllable
#113Carboranylporphyrins and uses thereof
#114Carboranylporphyrins and uses thereof
#115Conjugate
#116Conjugates comprising cancer cell specific ligands, a sugar and cancer chemotherapeutic agents/boron neutron capture therapy agents, and uses thereof
#117Delivery of neutron capture elements for neutron capture therapy
#118Agents for magnetic imaging method
#119Radionuclide labeling of vitamin Band coenzymes thereof
#120Human kininogen D3 domain polypeptide as an anti-angiogenic and anti-tumor agent